What Is Alcohol Use Disorder (AUD)?
Alcohol use disorder (AUD) is a chronic brain disease characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences. The DSM-5 classifies AUD as mild, moderate, or severe based on the number of 11 defined criteria a person meets over a 12-month period.
AUD is not a moral failing, a weakness of character, or a lack of willpower. Decades of neuroscience research have established it as a chronic brain disorder involving dysregulation of the dopaminergic reward system, hyperactivation of the stress response system, and progressive impairment of prefrontal cortical circuits governing decision-making. These neurobiological changes persist long after alcohol cessation — explaining why relapse risk remains elevated for months to years into recovery.
According to NIAAA, approximately 28.9 million Americans met criteria for AUD in 2023. Yet SAMHSA data indicates fewer than 10% received any specialty treatment — a treatment gap driven by stigma, cost concerns, and lack of awareness about effective options. If you or a loved one is struggling, our national rehab directory can help you find accredited treatment near you.
DSM-5 Criteria for Alcohol Use Disorder
A diagnosis of AUD requires meeting at least 2 of the following 11 criteria within a 12-month period:
← Swipe to scroll →
| # | Criterion | Category |
|---|---|---|
| 1 | Drinking more or for longer than intended | Loss of Control |
| 2 | Repeated unsuccessful efforts to cut down or stop | Loss of Control |
| 3 | Spending significant time drinking or recovering | Loss of Control |
| 4 | Strong cravings or urges to drink | Craving |
| 5 | Failing to fulfill major obligations due to drinking | Social Impairment |
| 6 | Continuing despite recurring social or interpersonal problems | Social Impairment |
| 7 | Giving up important activities because of alcohol | Social Impairment |
| 8 | Drinking in physically hazardous situations | Risky Use |
| 9 | Continuing despite knowing it causes or worsens a problem | Risky Use |
| 10 | Needing more alcohol for the same effect (tolerance) | Pharmacological |
| 11 | Withdrawal symptoms when stopping (shaking, sweating, anxiety) | Pharmacological |
Mild AUD = 2–3 criteria Moderate AUD = 4–5 criteria Severe AUD = 6+ criteria
You Don't Need to Hit "Rock Bottom"
The myth that someone must lose everything before seeking treatment is clinically false and has cost lives. NIAAA research shows that earlier intervention produces better outcomes. Mild and moderate AUD are highly treatable with outpatient care and FDA-approved medications. If you meet even 2 of the criteria above, speaking with a professional is the right move.
Why Alcohol Withdrawal Is Life-Threatening
Alcohol withdrawal is one of only two withdrawal syndromes (alongside benzodiazepines) that can be fatal without medical treatment. Understanding why requires understanding the neuroscience of alcohol dependence.
Alcohol acts primarily on GABA-A receptors — the brain's main inhibitory receptor system. With chronic use, the brain compensates by downregulating GABA activity and dramatically upregulating excitatory glutamate. The brain has recalibrated around the constant presence of alcohol. When alcohol is abruptly removed, this excitatory compensation is unmasked — producing a hyperexcitable state that can cascade from tremors to fatal seizures and delirium tremens within hours.
Never Stop Drinking Suddenly Without Medical Evaluation
If you drink heavily or daily, abrupt alcohol cessation can cause fatal seizures and delirium tremens (DTs) — a syndrome with up to 37% mortality without treatment. This risk can exist even without obvious symptoms of dependence. Do not attempt to stop drinking suddenly. Call (844) 561-0606 immediately for same-day medical detox placement.
Alcohol Withdrawal Timeline
Minor Withdrawal Begins
Anxiety, tremors ("the shakes"), nausea, vomiting, sweating, elevated heart rate and blood pressure, insomnia, headache. Begins even while blood alcohol may still be elevated in heavy drinkers.
Alcoholic Hallucinosis Risk
Visual, auditory, or tactile hallucinations occur in 10–25% of patients — typically in a clear sensorium (person is aware they may not be real), distinguishing them from the hallucinations of DTs.
Withdrawal Seizures — Medical Emergency
Generalized tonic-clonic (grand mal) seizures can occur in up to 10% of patients experiencing withdrawal — often with no warning. Prior history of withdrawal seizures is the strongest predictor of future seizures.
Delirium Tremens — Potentially Fatal
DTs affect approximately 5% experiencing withdrawal: severe autonomic instability, profound confusion, hallucinations, and cardiovascular collapse. Without treatment: up to 37% mortality. With proper medical care: below 5%.
Resolution — PAWS Begins
Acute withdrawal resolves within 5–10 days with medical management. Post-Acute Withdrawal Syndrome (PAWS) — anxiety, insomnia, mood instability, cognitive fog — can persist for weeks to months and is a primary driver of relapse in early recovery.
The CIWA-Ar: How Medical Detox Monitors Withdrawal
The Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) is a standardized 10-item scale used by nursing staff to measure withdrawal severity and guide medication dosing in real time. Scores above 8 require pharmacological management; scores above 15 indicate severe withdrawal. Symptom-triggered therapy guided by CIWA-Ar scores reduces total medication use and length of stay while maintaining equivalent safety outcomes.
Levels of Care for Alcohol Treatment
Treatment spans a continuum — the appropriate level depends on withdrawal risk, addiction severity, co-occurring conditions, and social circumstances. Learn more in our guide on inpatient vs. outpatient rehab.
Medical Detox (ASAM Level 4)
24/7 medically supervised withdrawal management with benzodiazepine therapy, IV thiamine, and real-time CIWA-Ar monitoring. Essential for any history of withdrawal complications or daily heavy drinking. Typically 5–10 days.
Learn about medical detox →Inpatient / Residential Rehab (ASAM Level 3)
Live-in structured treatment following detox: 28–90+ days of 24/7 clinical care, individual and group therapy, psychiatric services, and family therapy. Best for severe AUD, co-occurring disorders, prior relapse history, or unstable home environment. NIDA data: 90 days produces significantly better outcomes than 28.
Learn about inpatient rehab →Partial Hospitalization — PHP (ASAM Level 2.5)
Intensive day treatment (30+ hours/week, 5 days/week) while returning home evenings. Appropriate step-down from inpatient or primary treatment for moderate AUD with stable housing. 4–8 weeks typical.
Learn about PHP →Intensive Outpatient — IOP (ASAM Level 2.1)
9–19 hours/week of structured programming, day or evening sessions. Allows maintenance of work and family. For mild-moderate AUD or as step-down from PHP. Evening schedules available. 8–12 weeks typical.
Learn about IOP →Find Alcohol Rehab Near You
FDA-Approved Medications for Alcohol Use Disorder
Three FDA-approved medications treat alcohol use disorder. NIAAA estimates fewer than 10% of people with AUD who could benefit from medication ever receive it — one of the greatest missed opportunities in addiction medicine. All three are available by prescription from any physician. Learn more in our guide to medication-assisted treatment.
Naltrexone (ReVia / Vivitrol) FDA Approved 1994 / 2006
How it works: Blocks mu-opioid receptors involved in alcohol's reinforcing effects — specifically the dopamine release that makes drinking feel rewarding. Reduces craving and the pleasurable effects of drinking (the "buzz"), making it harder to justify continuing once a relapse begins.
Evidence: The COMBINE study — the largest pharmacotherapy RCT for AUD (N=1,383) — found naltrexone significantly improved abstinence rates and reduced heavy drinking days. Cochrane review (Jonas et al. 2014) across 53 trials confirms effectiveness.
Forms: Daily oral tablet (ReVia, 50mg) or once-monthly injection (Vivitrol, 380mg). Vivitrol eliminates compliance issues and is particularly useful for patients concerned about adherence.
Contraindications: Cannot be used while taking opioids (will cause precipitated withdrawal). Caution with liver disease. Does not require abstinence before starting — can reduce drinking in active drinkers.
Acamprosate (Campral) FDA Approved 2004
How it works: Normalizes glutamate/GABA imbalance that persists after alcohol cessation — reducing post-acute withdrawal symptoms (anxiety, insomnia, dysphoria) that drive relapse in early recovery. Unlike naltrexone, it reduces the discomfort of not drinking rather than the reward of drinking.
Evidence: Meta-analyses of over 4,000 patients show acamprosate significantly increases abstinence rates. Most effective in patients already abstinent and motivated to remain so. Safe in liver disease — an advantage over naltrexone.
Forms: Oral tablet taken three times daily. Requires consistent compliance for effectiveness. Start after detox is complete.
Contraindications: Severe kidney disease (renally cleared). Safe in liver disease.
Disulfiram (Antabuse) FDA Approved 1951
How it works: Inhibits aldehyde dehydrogenase — causing highly unpleasant reaction (flushing, nausea, palpitations, hypotension) when alcohol is consumed. Acts as a behavioral deterrent by creating negative consequences for drinking.
Evidence: Effectiveness depends entirely on compliance and motivation. Supervised administration (family member or clinician gives daily dose) significantly improves outcomes. Best for highly motivated patients with stable social support.
Important: Must avoid all alcohol-containing products (certain foods, mouthwash, cough syrups). Contraindicated in heart disease, severe liver disease, psychosis, and pregnancy.
Alcohol Medications Are Massively Underutilized
Only about 8% of people with AUD who could benefit from medication receive it. These medications are available from any physician — no addiction specialist required. When you call (844) 561-0606, we identify programs that incorporate medication management as a standard component of treatment. Also read our guide on naltrexone for alcohol use disorder.
Evidence-Based Therapies for Alcohol Addiction
Cognitive Behavioral Therapy (CBT)
Identifies thoughts and situations triggering drinking and builds specific coping skills — craving management, stress tolerance, refusal skills. Produces durable effects that outlast the treatment period.
Motivational Enhancement Therapy (MET)
4-session brief intervention using motivational interviewing to build internal motivation for change. Particularly effective in early stages when ambivalence is high.
12-Step Facilitation (AA)
Cochrane review (Humphreys et al. 2020) found AA participation associated with significantly higher abstinence rates at 1 and 3 years vs. other approaches. Community and accountability are powerful recovery supports.
Behavioral Couples Therapy (BCT)
For people in relationships, BCT addresses how the relationship system enables or triggers drinking. Strong evidence for reducing both alcohol use and relationship distress simultaneously.
Dialectical Behavior Therapy (DBT)
Builds emotion regulation, distress tolerance, and mindfulness. Particularly effective for AUD with co-occurring emotional dysregulation, PTSD, or borderline personality disorder.
SMART Recovery
Non-12-step, CBT-based mutual aid. Evidence-supported alternative for people who prefer a secular, science-based approach to peer support and long-term recovery maintenance. Visit SMART Recovery for meeting locations.
Co-Occurring Mental Health Conditions in AUD
Alcohol use disorder has among the highest rates of co-occurring psychiatric conditions of any substance use disorder. Treating both simultaneously — integrated dual diagnosis treatment — is essential for durable recovery:
- Major Depression: Up to 40% of people with AUD have experienced major depressive disorder. Alcohol worsens depression neurobiologically, and depression drives drinking as self-medication. Untreated depression is among the strongest predictors of relapse. Read our guide on depression and addiction.
- Anxiety Disorders: Social anxiety, generalized anxiety, and panic disorder are highly prevalent. Many people begin drinking specifically to manage anxiety — creating a cycle where alcohol temporarily relieves anxiety while worsening it through neuroadaptation over time.
- PTSD: Trauma exposure is strongly linked to AUD. Alcohol provides short-term relief from hyperarousal and intrusive memories — but PTSD must be specifically addressed in treatment. EMDR and trauma-focused CBT alongside AUD treatment show strong evidence.
- Bipolar Disorder: Co-occurring AUD in bipolar disorder is extremely common — studies estimate 40–60% prevalence. Alcohol worsens mood cycling and interferes with mood-stabilizing medications. Integrated treatment is essential.
When you call (844) 561-0606, tell us about any mental health history. We specifically identify programs with integrated dual diagnosis treatment capabilities. Learn more about dual diagnosis treatment.
Long-Term Health Consequences of Chronic Alcohol Use
- Liver disease: Progression from alcoholic fatty liver (reversible with abstinence) to alcoholic hepatitis (potentially fatal) to cirrhosis (irreversible scarring, liver failure, hepatocellular carcinoma) — the leading alcohol-attributable cause of death
- Neurological: Wernicke's encephalopathy from thiamine deficiency (acute: confusion, ataxia, eye movement abnormalities) progressing to Korsakoff syndrome (permanent memory impairment). Peripheral neuropathy. Cerebellar degeneration.
- Cardiovascular: Alcoholic cardiomyopathy, atrial fibrillation, hypertension, and stroke risk. Heavy drinking dramatically increases cardiovascular risk despite the widely misunderstood "benefits" of moderate drinking.
- Cancer: Alcohol is a Group 1 IARC carcinogen — causally linked to cancers of the mouth, pharynx, esophagus, larynx, liver, colon/rectum, and breast. Risk increases proportionally with consumption. Per the National Cancer Institute, no safe level of alcohol use for cancer risk exists.
- Gastrointestinal: Acute and chronic pancreatitis, gastritis, esophageal varices (life-threatening bleeding in cirrhosis), malabsorption syndromes.
Many of These Consequences Are Reversible With Early Treatment
Alcoholic fatty liver resolves within weeks of abstinence. Blood pressure, neurological function, and immune health improve significantly. Cancer risk decreases over time. The body has remarkable recovery capacity — but the window of reversibility narrows with continued use. Call (844) 561-0606 today or find a rehab center near you.
Does Insurance Cover Alcohol Rehab?
Yes — alcohol rehab is covered by most insurance plans under the Mental Health Parity and Addiction Equity Act (MHPAEA). Learn more on our insurance coverage page:
- Private insurance: Required to cover medically necessary alcohol treatment including detox, inpatient, PHP, IOP, and outpatient therapy. Coverage levels vary by plan.
- Medicaid: Covers alcohol treatment in all 50 states, including medical detox.
- Medicare: Part A covers inpatient detox hospitalization; Part B covers outpatient substance use treatment.
- No insurance: State-funded programs, sliding scale fees, and nonprofit facilities exist in every state. Call us and we'll identify every available option — no one should be denied treatment for inability to pay.
Use our free insurance verification tool to check your benefits before calling. It takes less than 60 seconds.
How to Choose an Alcohol Rehab Program
Not all programs are equal. When evaluating, specifically look for:
- CARF or Joint Commission accreditation
- Current, active state licensure as a substance use disorder facility
- 24/7 physician oversight and licensed nursing (critical for detox)
- FDA-approved medications (naltrexone, acamprosate, disulfiram) available within the program
- Evidence-based therapies: CBT, MET, 12-step facilitation documented in treatment plans
- On-site or readily accessible psychiatric services for dual diagnosis
- Individualized treatment planning — not one-size-fits-all programming
- Robust discharge planning connecting to step-down care, outpatient follow-up, and community support. Read our relapse prevention guide for what this looks like.
- LegitScript certification indicating ethical marketing practices
Alcohol Withdrawal Symptoms — What to Expect
If you or someone you love is approaching withdrawal, understanding the full symptom picture can be life-saving. We've covered this in detail in our comprehensive guide: Alcohol Withdrawal Symptoms, Timeline & When It Becomes an Emergency. Key points:
- Symptoms can begin as soon as 6 hours after the last drink
- DTs peak at 48–72 hours and require immediate hospitalization
- SAMHSA's National Helpline (1-800-662-4357) offers free referrals 24/7
- Medical detox dramatically reduces mortality and suffering
Frequently Asked Questions About Alcohol Rehab
Sources & Clinical References
- National Institute on Alcohol Abuse and Alcoholism (NIAAA). (2024). Alcohol Facts and Statistics. niaaa.nih.gov
- Centers for Disease Control and Prevention (CDC). (2022). Alcohol and Public Health: Alcohol-Related Disease Impact (ARDI). cdc.gov
- SAMHSA. (2024). Key Substance Use and Mental Health Indicators: Results from the 2023 NSDUH. samhsa.gov
- ASAM. (2020). Clinical Practice Guideline on Alcohol Withdrawal Management. asam.org
- Anton, R.F., et al. (2006). Combined pharmacotherapies and behavioral interventions for alcohol dependence (COMBINE). JAMA, 295(17), 2003–2017.
- Schuckit, M.A. (2014). Recognition and management of withdrawal delirium. New England Journal of Medicine, 371(22), 2109–2113.
- Jonas, D.E., et al. (2014). Pharmacotherapy for adults with alcohol use disorders in outpatient settings. JAMA, 311(18), 1889–1900.
- Humphreys, K., et al. (2020). Alcoholics Anonymous and other 12-step programs for AUD. Cochrane Database of Systematic Reviews, 3.
- Sullivan, J.T., et al. (1989). Assessment of alcohol withdrawal: The revised CIWA-Ar. British Journal of Addiction, 84, 1353–1357.